Related references
Note: Only part of the references are listed.The Alzheimer's therapeutic PBT2 promotes amyloid-β degradation and GSK3 phosphorylation via a metal chaperone activity
Peter J. Crouch et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Subclinical Zinc Deficiency in Alzheimer's Disease and Parkinson's Disease
George J. Brewer et al.
AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS (2010)
Serum zinc is decreased in Alzheimer's disease and serum arsenic correlates positively with cognitive ability
Larry Baum et al.
BIOMETALS (2010)
Is cognitive function linked to serum free copper levels? A cohort study in a normal population
Carlo Salustri et al.
CLINICAL NEUROPHYSIOLOGY (2010)
Cognitive Loss in Zinc Transporter-3 Knock-Out Mice: A Phenocopy for the Synaptic and Memory Deficits of Alzheimer's Disease?
Paul A. Adlard et al.
JOURNAL OF NEUROSCIENCE (2010)
Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction
C. Corona et al.
CELL DEATH & DISEASE (2010)
Longitudinal prognostic value of serum free copper in patients with Alzheimer disease
R. Squitti et al.
NEUROLOGY (2009)
Ctr1 drives intestinal copper absorption and is essential for growth, iron metabolism, and neonatal cardiac function
Yasuhiro Nose et al.
CELL METABOLISM (2006)
Dietary copper and high saturated and trans fat intakes associated with cognitive decline
Martha Clare Morris et al.
ARCHIVES OF NEUROLOGY (2006)
Excess of nonceruloplasmin serum copper in AD correlates with MMSE, CSF β-amyloid, and h-tau
R. Squitti et al.
NEUROLOGY (2006)
Copper binding properties of a tau peptide associated with Alzheimer's disease studied by CD, NMR, and MALDI-TOF MS
QF Ma et al.
PEPTIDES (2006)
Treatment of Wilson disease with ammonium tetrathiomolybdate - IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease
GJ Brewer et al.
ARCHIVES OF NEUROLOGY (2006)
Excess of serum copper not related to ceruloplasmin in Alzheimer disease
R Squitti et al.
NEUROLOGY (2005)
Oxidation of cholesterol by amyloid precursor protein and β-amyloid peptide
TJ Nelson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Copper-mediated LDL oxidation by homocysteine and related compounds depends largely on copper ligation
E Nakano et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2004)
Trace amounts of copper in water induce b-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease
DL Sparks et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Transferrin C2 variant does confer a risk for Alzheimer's disease in caucasians
Pamela Zambenedetti et al.
JOURNAL OF ALZHEIMERS DISEASE (2003)
Plasma homocysteine as a risk factor for dementia and Alzheimer's disease.
S Seshadri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: A central role for bound transition metals
LM Sayre et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Share Paper
